Glycosylation as a strategy to improve antibody-based therapeutics

Jefferis, Roy·2009·Nature Reviews Drug Discovery

Cited by (763)

Items 301–400 of 763

  1. Engineering the interactions between a plant‐produced HIV antibody and human Fc receptors
    Szymon Stelter, Matthew John Paul, Audrey Y‐H. Teh, Melanie Grandits, Friedrich Altmann, Jessica Vanier, Muriel Bardor, Alexandra Castilho, Rachel Louise Allen, Julian K‐C. · 2019 · Plant Biotechnology Journal
  2. Fcγ1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties
    Saman Soleimanpour, Tahereh Hassannia, Motiee Mahdieh, Abbas Ali Amini, Seyed Abdolrahim Rezaee · 2016 · Critical Reviews in Biotechnology
  3. Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS
    Sheng Liu, Wen-Jie Gao, Yao Wang, Zhenyu He, Xiao-Jun Feng, Bi-Feng Liu, Xin Liu · 2017 · PLoS ONE
  4. Straightforward Glycoengineering Approach to Site-Specific Antibody-Pyrrolobenzodiazepine Conjugates.
    Pamela Thompson, Ebele Ezeadi, I. Hutchinson, Ryan L. Fleming, Binyam Z Bezabeh, Jia Lin, Shen-Lan Mao, Cui Chen, Luke A. Masterson, H. Zhong et al. · 2016 · ACS Medicinal Chemistry Letters
  5. Identification of Low Abundant Isomeric N-Glycan Structures in Biological Therapeutics by LC/MS.
    Jia Zhao, Si-Yang Li, Chen Li, Shiaw-lin Wu, Wei Xu, Yuetian Chen, M. Shameem, D. Richardson, Huijuan Li · 2016 · Analytical Chemistry
  6. Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297
    Mohammad A. Alsenaidy, Solomon Z. Okbazghi, Jae Hyun Kim, S. Joshi, C. Middaugh, Tom Tolbert, D. Volkin · 2014 · Journal of Pharmacy and Science
  7. Comparison of ZIC-HILIC and graphitized carbon-based analytical approaches combined with exoglycosidase digestions for analysis of glycans from monoclonal antibodies
    Lea Mauko, Nathan A. Lacher, Matthias Pelzing, Anna Nordborg, Paul R. Haddad, Emily Frances Hilder · 2012 · Journal of Chromatography B
  8. Next-Generation (Glycomic) Biomarkers for Cardiometabolic Health: A Community-Based Study of Immunoglobulin G N -Glycans in a Chinese Han Population
    Hao Wang, Xingang Li, Xueqing Wang, Di Liu, Xiaoyu Zhang, Weijie Cao, Yulu Zheng, Zheng Guo, Dong Li, Weijia Xing et al. · 2019 · OMICS A Journal of Integrative Biology
  9. Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
    C. Eakin, Amanda K. Miller, Jennifer Kerr, James Kung, A. Wallace · 2014 · Frontiers in Pharmacology
  10. Biosimilars in psoriasis: What can we expect?
    M. Radtke, M. Augustin · 2014 · Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
  11. Aminooxylated Carbohydrates: Synthesis and Applications.
    Carlo Pifferi, G. Daskhan, M. Fiore, T. Shiao, R. Roy, O. Renaudet · 2017 · Chemical Reviews
  12. Glycosylation analysis of an aggregated antibody produced by Chinese hamster ovary cells in bioreactor culture
    Masayoshi Onitsuka, Akira Kawaguchi, Ryutaro Asano, Izumi Kumagai, Kohsuke Honda, Hisao Ohtake, Takeshi Ōmasa · 2013 · Journal of Bioscience and Bioengineering
  13. In-Depth Characterization of N-Linked Oligosaccharides Using Fluoride-Mediated Negative Ion Microfluidic Chip LC–MS
    Wenqin Ni, Jonathan Bones, Barry L. Karger · 2013 · Analytical Chemistry
  14. Application of Quantitative Pharmacology in Development of Therapeutic Monoclonal Antibodies
    Mohammad A. Tabrizi, Cherryl B. Funelas, Hamza Suria · 2010 · The AAPS Journal
  15. The glycobiology of brain tumors: disease relevance and therapeutic potential
    Joseph R. Moskal, Roger A. Kroes, Glyn Dawson · 2009 · Expert Review of Neurotherapeutics
  16. Combinatorial genome and protein engineering yields monoclonal antibodies with hypergalactosylation from CHO cells
    Chung, Cheng‐yu, Wang, Qiong, Yang, Shuang, Ponce, Sean A., Kirsch, Brian J., Zhang, Hui, Betenbaugh, Michael J. · 2017 · Biotechnology and Bioengineering
  17. Cell-Free Synthetic Glycobiology: Designing and Engineering Glycomolecules Outside of Living Cells
    Thapakorn Jaroentomeechai, May N. Taw, Mingji Li, Alicia K. Aquino, Ninad Agashe, Sean S. Chung, Michael C. Jewett, Matthew P. DeLisa · 2020 · Frontiers in Chemistry
  18. Consequences of glycan truncation on Fc structural integrity
    Patrick M. Buck, Sandeep Kumar, Satish Kumar Singh · 2013 · mAbs
  19. Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E cells
    Sophie Nallet, Luca Fornelli, Simone Schmitt, Julien Parra, Lucia Baldi, Yury O. Tsybin, Florian Maria Wurm · 2012 · New Biotechnology
  20. The effect of hyperosmolality application time on production, quality, and biopotency of monoclonal antibodies produced in CHO cell fed-batch and perfusion cultures
    Jinyan Qin, Xiang Xia Wu, Zhigang Xia, Zheng Huang, Ying Zhang, Yanchao Wang, Qiang Fu, Chen Zheng · 2018 · Applied Microbiology and Biotechnology
  21. Glycosylation status of serum immunoglobulin G in patients with prostate diseases
    S. Kazuno, Jun-ichi Furukawa, Yasuro Shinohara, K. Murayama, M. Fujime, T. Ueno, T. Fujimura · 2016 · Cancer Medicine
  22. Functional assessment of antibody oxidation by native mass spectrometry
    Markus Haberger, Anna-Katharina Heidenreich, Tilman Schlothauer, Michaela Hook, Jana Gassner, Katrin Bomans, Michelle Yegres, Adrian Zwick, Boris Zimmermann, Harald Wegele et al. · 2015 · mAbs
  23. Challenges in Protein Product Development
    N. Warne, H. Mahler · 2018 · AAPS Advances in the Pharmaceutical Sciences Series
  24. Separation of Sialylated Glycan Isomers by Differential Mobility Spectrometry
    C. Lane, K. McManus, Philip J. Widdowson, S. A. Flowers, Gerard Powell, Ian Anderson, J. Campbell · 2019 · Analytical Chemistry
  25. Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen
    Andrew G. Diamos, Dalia Larios, L. Brown, Jacquelyn Kilbourne, Hyun Kim, Divyasha Saxena, K. Palmer, H. Mason · 2018 · Vaccine
  26. N‐glycan engineering of a plant‐produced anti‐CD20‐hIL‐2 immunocytokine significantly enhances its effector functions
    C. Marusic, C. Pioli, Szymon Stelter, F. Novelli, Chiara Lonoce, Elena Morrocchi, E. Benvenuto, A. Salzano, A. Scaloni, M. Donini · 2018 · Biotechnology and Bioengineering
  27. Site-Selective Chemoenzymatic Glycosylation of an HIV-1 Polypeptide Antigen with Two Distinct N-Glycans via an Orthogonal Protecting Group Strategy
    Christian Toonstra, Mohammed A. Amin, Lai‐Xi Wang · 2016 · The Journal of Organic Chemistry
  28. Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms
    Apurva S. More, Vishal M. Toprani, Solomon Z. Okbazghi, Jae H. Kim, Sangeeta B. Joshi, Charles Russell Middaugh, Thomas J. Tolbert, David B. Volkin · 2015 · Journal of Pharmaceutical Sciences
  29. Driving CAR-Based T-Cell Therapy to Success
    Bipulendu Jena, Judy S. E. Moyes, Helen M. Huls, Laurence J.N. Cooper · 2014 · Current Hematologic Malignancy Reports
  30. Production of Plant Made Pharmaceuticals: From Plant Host to Functional Protein
    Bieke Nagels, Koen Weterings, Nico Callewaert, Els J. M. Van Damme · 2012 · Critical Reviews in Plant Sciences
  31. Plant production of anti‐β‐glucan antibodies for immunotherapy of fungal infections in humans
    Cristina Capodicasa, Paola Chiani, Carla Bromuro, Flavia De Bernardis, Marcello Catellani, Angelina S. Palma, Yan Liu, Ten Feizi, Antonio Cassone, Eugenio Benvenuto et al. · 2011 · Plant Biotechnology Journal
  32. Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
    Manjari Kundu, Yoshimi Endo Greer, Jennifer L. Dine, Stanley Lipkowitz · 2022 · Cells
  33. Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications
    Rozita Naseri, Seyed Jafar Navabi, Zeinab Samimi, Abhay Prakash Mishra, Manisha Nigam, Harish Chandra, Ahmed Olatunde, Habibu Tijjani, Raquel P. Morais‐Urano, Mohammad Hosein Farzaei · 2020 · DARU Journal of Pharmaceutical Sciences
  34. Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
    Emma R. Job, Tine Ysenbaert, Anne-Sophie de Smet, Annelies Van Hecke, Leander Meuris, Harry Kleanthous, Xavier Saelens, Thorsten U. Vogel · 2019 · mBio
  35. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques
    Leia K. Miller-Novak, Jishnu Das, Thomas Musich, T. Demberg, Joshua A. Weiner, D. Venzon, V. Mohanram, Diego A. Vargas-Inchaustegui, I. Tuero, M. Ackerman et al. · 2018 · Journal of Virology
  36. Cell culture media supplemented with raffinose reproducibly enhances high mannose glycan formation.
    David Brühlmann, A. Muhr, R. Parker, T. Vuillemin, Blanka Bucsella, F. Kalman, Serena Torre, F. La Neve, Antonio Lembo, T. Haas et al. · 2017 · Journal of Biotechnology
  37. Orthogonal Assessment of Biotherapeutic Glycosylation: A Case Study Correlating N-Glycan Core Afucosylation of Herceptin with Mechanism of Action
    Rosie Upton, Leonard Bell, Colin P. Guy, Paul Caldwell, Siân Estdale, Perdita E. Barran, David F. Firth · 2016 · Analytical Chemistry
  38. Evaluating the bottlenecks of recombinant IgM production in mammalian cells
    Veronika Chromikova, Alexander Mäder, Willibald Steinfellner, Renate Kunert · 2014 · Cytotechnology
  39. Lepidopteran cells, an alternative for the production of recombinant antibodies?
    Martine Cérutti, Josée Golay · 2012 · mAbs
  40. The Amazing Transglycosylation Activity of Endo-β-N-Acetylglucosaminidases
    Lai‐Xi Wang · 2011 · Trends in Glycoscience and Glycotechnology
  41. Glycomics in Human Diseases and Its Emerging Role in Biomarker Discovery
    Sherifdeen Bamidele Onigbinde, Moyinoluwa Adeniyi, Oluwatosin Emmanuel Daramola, F. M. Chukwubueze, Md Mostofa Al Amin Bhuiyan, Judith Ijeoma Nwaiwu, Tuli Bhattacharjee, Yehia S. Mechref · 2025 · Biomedicines
  42. The importance of IgG N-glycosylation in Health, Disease, and Neonatal hemochromatosis
    Kujtim Thaçi, Robert M. Anthony · 2025 · Glycoscience & Therapy
  43. Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients
    Jing Han, Zhuochao Zhou, Rongrong Zhang, Yijun You, Zizhen Guo, Jinyan Huang, Fan Wang, Yue Sun, Honglei Liu, Xiaobing Cheng et al. · 2022 · EBioMedicine
  44. Human disease glycomics: technology advances enabling protein glycosylation analysis – part 2
    Arun Everest‐Dass, Edward S. X. Moh, Christopher Ashwood, Abdulrahman M M Shathili, Nicolle H. Packer · 2018 · Expert Review of Proteomics
  45. Producing defucosylated antibodies with enhanced in vitro antibody‐dependent cellular cytotoxicity via FUT8 knockout CHO‐S cells
    Huifang Zong, Lei Han, Kai Ding, Jiaxian Wang, Tao Sun, Xinyu Zhang, Cédric Cagliero, Hua Jiang, Yueqing Xie, Jianrong Xu et al. · 2017 · Engineering in Life Sciences
  46. DNA‐Templated Introduction of an Aldehyde Handle in Proteins
    Anne Louise Bank Kodal, Christian B. Rosen, Michael R. Mortensen, Thomas Tørring, Kurt V. Gothelf · 2016 · ChemBioChem
  47. Quantitation of Site-Specific Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs
    Nan Yang, Elisha Goonatilleke, Dayoung Park, Ting Song, Guorong Fan, Carlito B. Lebrilla · 2016 · Analytical Chemistry
  48. Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors
    Yuya Isoda, Hirokazu Yagi, Tadashi Satoh, Mami Shibata‐Koyama, Kazuhiro Masuda, Mitsuo Satoh, Koichi Kato, Shigeru Iida · 2015 · PLoS ONE
  49. Engineering Upper Hinge Improves Stability and Effector Function of a Human IgG1
    Boxu Yan, Daniel Boyd, Timothy Kaschak, Joni Tsukuda, Amy Y. Shen, Yuwen Linda Lin, Shan Chung, Priyanka Gupta, Amrita V. Kamath, Anne Wong et al. · 2011 · Journal of Biological Chemistry
  50. Ethyl Esterification for MALDI-MS Analysis of Protein Glycosylation.
    K. Reiding, Emanuela Lonardi, A. Hipgrave Ederveen, M. Wuhrer · 2016 · Methods in molecular biology
  51. Glycosylation pattern of humanized IgG-like bispecific antibody produced by recombinant CHO cells
    Wook-Dong Kim, Miwako Tokunaga, Hiroyuki Ozaki, Takuya Ishibashi, Kohsuke Honda, Hiroyuki Kajiura, Kazuhito Fujiyama, Ryutaro Asano, Izumi Kumagai, Takeshi Ōmasa et al. · 2009 · Applied Microbiology and Biotechnology
  52. Neuronal C‐Reactive Protein/Fc γ RI Positive Feedback Proinflammatory Signaling Contributes to Nerve Injury Induced Neuropathic Pain
    Fan Liu, Li Zhang, Si Su, Yehong Fang, Xiang‐sha Yin, Huan Cui, Jianru Sun, Yikuan Xie, Chao Ma · 2023 · Advanced Science
  53. Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies
    Xinhai Chen, Miaomiao Shi, Xin Tong, Hwan Keun Kim, Lai‐Xi Wang, Olaf Schneewind, Dominique M. Missiakas · 2020 · Proceedings of the National Academy of Sciences
  54. Chemoenzymatic synthesis of glycoproteins.
    A. Fairbanks · 2019 · Current Opinion in Chemical Biology
  55. State‐of‐the‐art technologies for rapid and high‐throughput sample preparation and analysis of N‐glycans from antibodies
    Udayanath Aich, Jude C. Lakbub, Aston Liu · 2016 · Electrophoresis
  56. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody
    Matthew C. Cook, Sherif James Kaldas, Gauri Muradia, Michael Rosu‐Myles, Jeremy P. Kunkel · 2015 · Journal of Chromatography B
  57. Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody
    Hans D. Brightbill, Yuwen Linda Lin, Zhonghua Lin, Martha Tan, Y. Meng, Mercedesz Balázs, Shan Chung, Lawren C. Wu · 2013 · Clinical Anti-Inflammatory & Anti-Allergy Drugs
  58. Challenges in O-glycan engineering of plants
    R. Strasser · 2012 · Frontiers in Plant Science
  59. Combining machine learning with structure-based protein design to predict and engineer post-translational modifications of proteins
    Moritz Ertelt, Vikram Khipple Mulligan, Jack B. Maguire, Sergey Lyskov, Rocco Moretti, Torben Schiffner, Jens Meiler, Clara T. Schoeder · 2024 · PLoS Computational Biology
  60. Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?
    Coco R. Beudeker, Daniel C. Vijlbrief, Joris M. van Montfrans, Suzan H. M. Rooijakkers, Michiel van der Flier · 2022 · Frontiers in Immunology
  61. Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model
    Paul Engeroff, Kevin Plattner, Federico Storni, Franziska Thoms, Kayluz Frias Boligan, Lukas Muerner, Alexander Eggel, Stephan von Gunten, Martin F. Bachmann, Monique Vogel · 2020 · Journal of Allergy and Clinical Immunology
  62. Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases
    Yuliya V. Markina, Герасимова Елена Владимировна, Alexander M. Markin, Victor Yu. Glanz, Wei‐Kai Wu, Igor Alexandrovich Sobenin, Alexander Nikolaevich Orekhov · 2020 · International Journal of Molecular Sciences
  63. The transgenic chicken derived anti-CD20 monoclonal antibodies exhibits greater anti-cancer therapeutic potential with enhanced Fc effector functions
    Young Min Kim, Jin Se Park, Sang Kyung Kim, Kyung Min Jung, Young Sun Hwang, Mookyoung Han, Hong Jo Lee, Hee Won Seo, Jeong‐Yong Suh, Beom Ku Han et al. · 2018 · Biomaterials
  64. Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
    Kerry M. Wooding, Wenjing Peng, Yehia S. Mechref · 2016 · Current Pharmaceutical Biotechnology
  65. At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody
    Chuanfei Yu, Kai Gao, Lei Zhu, Wenbo Wang, Lan Wang, Feng Zhang, Chunyu Liu, Meng Li, Mark R. Wormald, Pauline Mary Rudd et al. · 2016 · Scientific Reports
  66. Glycoprotein Labeling with Click Chemistry (GLCC)
    Zheng-Liang L. Wu, Xin-Yi Huang, A. Burton, K. Swift · 2015 · Carbohydrate Research
  67. Contribution of animal studies to evaluate the similarity of biosimilars to reference products.
    P. V. van Meer, H. Ebbers, M. Kooijman, C. G. Gispen-de Wied, B. Silva‐Lima, E. Moors, H. Schellekens · 2015 · Drug Discovery Today
  68. Monoclonal Antibodies as Therapeutics in Human Malignancies
    Manjari Pandey, Daruka Mahadevan · 2014 · Future Oncology
  69. Biologically active, magnICON®-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures.
    Bieke Nagels, E. V. van Damme, N. Callewaert, L. Zabeau, J. Tavernier, J. Delanghe, A. Boets, A. Castilho, K. Weterings · 2012 · Journal of Biotechnology
  70. Application of partial‐filling capillary electrophoresis using lectins and glycosidases for the characterization of oligosaccharides in a therapeutic antibody
    Yuki Yagi, Sachio Yamamoto, Kazuaki Kakehi, Takao Hayakawa, Yukihito Ohyama, Shigeo Suzuki · 2011 · Electrophoresis
  71. Passive Immunization with Allergen-Specific Antibodies
    Sabine Flicker, Elisabeth Gadermaier, Christoph Madritsch, Rudolf Valenta · 2011 · Current topics in microbiology and immunology
  72. Rapid biosynthesis of glycoprotein therapeutics and vaccines from freeze-dried bacterial cell lysates
    Jessica C. Stark, Thapakorn Jaroentomeechai, Katherine F. Warfel, Jasmine M. Hershewe, M. DeLisa, Michael C. Jewett · 2023 · Nature Protocols
  73. Integrating Intact Mass Analysis and Middle-Down Mass Spectrometry Approaches to Effectively Characterize Trastuzumab and Adalimumab Structural Heterogeneity
    Wenwen Zhu, Menglin Li, Jinlan Zhang · 2020 · Journal of Proteome Research
  74. Survival of Recombinant Monoclonal Antibodies (IgG, IgA and sIgA) Versus Naturally-Occurring Antibodies (IgG and sIgA/IgA) in an Ex Vivo Infant Digestion Model
    Jiraporn Lueangsakulthai, Baidya Nath P. Sah, Brian P. Scottoline, David Charles Dallas · 2020 · Nutrients
  75. Characterization of recombinant monoclonal antibody charge variants using WCX chromatography, icIEF and LC-MS/MS
    Hailong Liu, Weicheng Ren, Li Zong, Jinliang Zhang, Yingwu Wang · 2018 · Analytical Biochemistry
  76. Current landscape of protein glycosylation analysis and recent progress toward a novel paradigm of glycoscience research
    Sachio Yamamoto, Mitsuhiro Kinoshita, Shigeo Suzuki · 2016 · Journal of Pharmaceutical and Biomedical Analysis
  77. Significant Impact of Single N-Glycan Residues on the Biological Activity of Fc-based Antibody-like Fragments
    Jakub Jeż, Bernhard Antes, Alexandra Castilho, Manuela Kainer, Susanne Wiederkum, Josephine Grass, Florian Rüker, Max Woisetschläger, Herta Steinkellner · 2012 · Journal of Biological Chemistry
  78. Protein Expression Platforms and the Challenges of Viral Antigen Production
    Jamie R. V. Sookhoo, Zachary Schiffman, Aruna P. N. Ambagala, Darwyn Kobasa, Keith Pardee, Shawn Babiuk · 2024 · Vaccines
  79. Immunoglobulin G glycosylation and its alterations in aging-related diseases
    Yongqi Wu, Zhida Zhang, Lin Chen, Shisheng Sun · 2024 · Acta Biochimica et Biophysica Sinica
  80. Bioproduced Proteins On Demand (Bio-POD) in hydrogels using Pichia pastoris
    Shuo‐Fu Yuan, Sierra M. Brooks, Annalee W. Nguyen, Wen-Ling Lin, Trevor G. Johnston, Jennifer A. Maynard, Alshakim Nelson, Hal S. Alper · 2021 · Bioactive Materials
  81. Targeted Bottom-up Characterization of Recombinant Monoclonal Antibodies by Multidimensional LC/MS
    Julien Camperi, Davy Guillarme, Cinzia Stella · 2020 · Analytical Chemistry
  82. Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope
    Arathi Kizhedath, Simon C Wilkinson, Jarka Glassey · 2016 · Archives of Toxicology
  83. A comparison of orbitally‐shaken and stirred‐tank bioreactors: pH modulation and bioreactor type affect CHO cell growth and protein glycosylation
    D. Monteil, Valentin Juvet, Jonathan Paz, M. Moniatte, L. Baldi, D. Hacker, F. Wurm · 2016 · Biotechnology progress (Print)
  84. Ultrafast and high-throughput N-glycan analysis for monoclonal antibodies
    Xiaoyu Yang, Sunnie Kim, Richard Ruzanski, Yuetian Chen, S. Moses, Wai-Lam W. Ling, Xiaojuan Li, Shao-Chun Wang, Huijuan Li, A. Ambrogelly et al. · 2016 · mAbs
  85. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics
    Ryutaro Asano, Ippei Shimomura, Shota Konno, Akiko Ito, Yosuke Masakari, Ryota Orimo, Shintaro Taki, Kyoko Arai, Hiromi Ogata, Mai Okada et al. · 2014 · mAbs
  86. Ultrasensitive Capillary Electrophoretic Analysis of Potentially Immunogenic Carbohydrate Residues in Biologics: Galactose-α-1,3-Galactose Containing Oligosaccharides
    Z. Szabó, A. Guttman, J. Bones, R. L. Shand, D. Meh, B. Karger · 2012 · Molecular Pharmaceutics
  87. Development and qualification of an antibody rapid deglycosylation method.
    K. Cook, K. Bullock, T. Sullivan · 2012 · Biologicals (Print)
  88. IgG N-glycans
    Si Liu, Xin Liu · 2021 · Advances in clinical chemistry
  89. Chemoenzymatic Glyco-engineering of Monoclonal Antibodies
    John P. Giddens, Lai‐Xi Wang · 2015 · Methods in molecular biology
  90. Sequence Variants and Sequence Variant Analysis in Biotherapeutic Proteins
    Oleg V. Borisov, Melissa Alvarez, James A. Carroll, Paul Wencil Brown · 2015 · ACS symposium series
  91. Fc Engineering: Design, Expression, and Functional Characterization of Antibody Variants with Improved Effector Function
    Stefanie Derer, Christian Kellner, Sven Berger, Thomas Valerius, Matthias Peipp · 2012 · Methods in molecular biology
  92. Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment
    Laura R. R. Mijangos, Stephen E. Harding, Nicholas J. Darton · 2025 · Biophysical Reviews
  93. Structural insights into the mechanisms and specificities of IgG-active endoglycosidases
    Jonathan J. Du, Erik H. Klontz, Marcelo E. Guerin, Beatriz Trastoy, Eric J. Sundberg · 2019 · Glycobiology
  94. IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age
    Nele Twisselmann, Yannic C. Bartsch, Julia Pagel, Christian Wieg, Annika Hartz, Marc Ehlers, Christoph Härtel · 2019 · Frontiers in Immunology
  95. Antibody mimetics: promising complementary agents to animal-sourced antibodies
    Abdul Rasheed Baloch, A. W. Baloch, B. Sutton, Xiaoying Zhang · 2016 · Critical Reviews in Biotechnology
  96. Update on obinutuzumab in the treatment of B-cell malignancies
    T. Illidge, E. Cheadle, C. Donaghy, J. Honeychurch · 2014 · Expert Opinion on Biological Therapy
  97. Vaccination with recombinant Lactococcus lactis expressing HA1-IgY Fc fusion protein provides protective mucosal immunity against H9N2 avian influenza virus in chickens
    Ruihua Zhang, Tong Xu, Zi-Ping Li, Longfei Li, Chun-hong Li, Xinrui Li, Zhi-Yue Wang, Shaohua Wang, Xue-jing Wang, Hong-Liang Zhang · 2023 · Virology Journal
  98. Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
    Chiara Elisabeth Geyer, Lynn Mes, Melissa Newling, Jeroen den Dunnen, Willianne Hoepel · 2021 · Cells
  99. Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties
    Steffen Lippold, Simone Nicolardi, Manfred Wuhrer, David Falck · 2019 · Frontiers in Chemistry
  100. Using bispecific antibodies in forced degradation studies to analyze the structure–function relationships of symmetrically and asymmetrically modified antibodies
    Adam R. Evans, Michael T. Capaldi, Geetha N. Goparaju, David C. Colter, Frank F. Shi, Sarah Aubert, Lian‐Chao Li, Jingjie Mo, Michael J. Lewis, Ping Hu et al. · 2019 · mAbs